{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:31:44Z","timestamp":1787002304312,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2015.43","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T10:29:20Z","timestamp":1433500160000},"page":"e318-e318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9384-272X","authenticated-orcid":false,"given":"A","family":"Rashidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F","family":"Cashen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,5]]},"reference":[{"key":"BFbcj201543_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s12185-012-1081-2","volume":"95","author":"A Rashidi","year":"2012","unstructured":"Rashidi A, Lee ME, Fisher SI . Hepatosplenic alphabeta T-cell lymphoma associated with azathioprine therapy. Int J Hematol 2012; 95: 592\u2013594.","journal-title":"Int J Hematol"},{"key":"BFbcj201543_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.crohns.2010.05.006","volume":"4","author":"A Thai","year":"2010","unstructured":"Thai A, Prindiville T . Hepatosplenic T-cell lymphoma and inflammatory bowel disease. J Crohn's Colitis 2010; 4: 511\u2013522.","journal-title":"J Crohn's Colitis"},{"key":"BFbcj201543_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/ejh.12439","volume":"94","author":"M Foppoli","year":"2015","unstructured":"Foppoli M, Ferreri AJ . Gamma-delta T-cell lymphomas. Eur J Haematol 2015; 94: 206\u2013218.","journal-title":"Eur J Haematol"},{"key":"BFbcj201543_CR4","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1097\/MEG.0b013e32834bb90a","volume":"23","author":"D Parakkal","year":"2011","unstructured":"Parakkal D, Sifuentes H, Semer R, Ehrenpreis ED . Hepatosplenic T-cell lymphoma in patients receiving TNF-alpha inhibitor therapy: expanding the groups at risk. Eur J Gastroenterol Hepatol 2011; 23: 1150\u20131156.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFbcj201543_CR5","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","volume":"127","author":"F Vega","year":"2007","unstructured":"Vega F, Medeiros LJ, Gaulard P . Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol 2007; 127: 869\u2013880.","journal-title":"Am J Clin Pathol"},{"key":"BFbcj201543_CR6","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1080\/10428190310001609924","volume":"45","author":"A Chanan-Khan","year":"2004","unstructured":"Chanan-Khan A, Islam T, Alam A, Miller KC, Gibbs J, Barcos M et al. Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha\/beta hepatosplenic T-cell non-Hodgkin's lymphoma. Leuk Lymphoma 2004; 45: 1673\u20131675.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj201543_CR7","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1080\/10428190701400071","volume":"48","author":"S He","year":"2007","unstructured":"He S, Roberts A, Ritchie D, Grigg A . Graft-versus-lymphoma effect in progressive hepatosplenic gamma\/delta T-cell lymphoma. Leuk Lymphoma 2007; 48: 1448\u20131450.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj201543_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clml.2012.09.002","volume":"13","author":"MH Voss","year":"2013","unstructured":"Voss MH, Lunning MA, Maragulia JC, Papadopoulos EB, Goldberg J, Zelenetz AD et al. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience. Clin Lymphoma Myeloma Leuk 2013; 13: 8\u201314.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"BFbcj201543_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1532\/IJH97.04149","volume":"82","author":"T Takaku","year":"2005","unstructured":"Takaku T, Miyazawa K, Sashida G, Shoji N, Shimamoto T, Yamaguchi N et al. Hepatosplenic alphabeta T-cell lymphoma with myelodysplastic syndrome. Int J Hematol 2005; 82: 143\u2013147.","journal-title":"Int J Hematol"},{"key":"BFbcj201543_CR10","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1182\/blood.V122.21.3032.3032","volume":"122","author":"AR Shustov","year":"2013","unstructured":"Shustov AR, Wilson WH, Beaven AW, Savage KJ, Carson KR, Hernandez-Ilizaliturri FJ et al. Hepatosplenic T-cell lymphoma: clinicopathological features and treatment outcomes: report from the North American Peripheral T-Cell Lymphoma Consortium. Blood 2013; 122: 3032.","journal-title":"Blood"},{"key":"BFbcj201543_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/leu.2014.280","volume":"29","author":"A Tanase","year":"2015","unstructured":"Tanase A, Schmitz N, Stein H, Boumendil A, Finel H, Castagna L et al. Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party. Leukemia 2015; 29: 686\u2013688.","journal-title":"Leukemia"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201543","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:00:25Z","timestamp":1672894825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,5]]},"references-count":11,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6]]}},"alternative-id":["BFbcj201543"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2015.43","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,5]]},"assertion":[{"value":"5 June 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}